Auris Medical Holding AG (EARS) was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 18.5% since Dec 4, 2014.
The company has seen no estimate revisions in the past 7 days and the Zacks Consensus Estimate has also remained unchanged over the same time frame. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Auris Medical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked biotechnology stock is Biodel Inc. (BIOD), sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AURIS MEDICAL (EARS): Free Stock Analysis Report
BIODEL INC (BIOD): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research